Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
University of Nebraska
Adela, Inc
Mayo Clinic
University of Alabama at Birmingham